Search results for 'Prescription Drugs'
-
Prophylaxis of Japanese encephalitis
-
Improvement of dizziness caused by chronic cerebral circulation disorder following cerebral infarction
-
Once-daily subcutaneous administration for the treatment of adult and pediatric patients with type 1 diabetes mellitus or adult patients with type 2 diabetes mellitus who require basal (long-acting) insulin for the control of hyperglycemia.
-
1) Management of edema associated with heart failure (i.e. congestive heart failure), cirrhosis of the liver (i.e. ascites), or renal disease; acute pulmonary edema 2) Management of essential or renal hypertension
-
1) Management of edema associated with heart failure (i.e. congestive heart failure), cirrhosis of the liver (i.e. ascites), or renal disease; peripheral vascular edema 2) Management of essential or renal hypertension
-
Hyperlipidemia: hypercholesterolemia (type IIa), combined type of hypercholesterolemia and hypertriglyceridemia (type IIb, type III), hypertriglyceridemia (type IV)
Metabolism / Cardiovascular
-
Hyperlipidemia: hypercholesterolemia (type IIa), combined type of hypercholesterolemia and hypertriglyceridemia (type IIb, type III), hypertriglyceridemia (type IV)
Metabolism / Cardiovascular
-
Primary hypercholesterolemia: As an adjuvant to diet to reduce elevated total-cholesterol, LDL-cholesterol, apolipoprotein-B, triglycerides and non-HDL-cholesterol, and to increase HDL-cholesterol in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) or mixed dyslipidemia
-
Active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra is approved for use in individuals 9 months through 55 years of age